1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > 2017 Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape-US, Europe (France, Germany, Italy, Spain, UK), Japan

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5-year test volume and sales forecasts by country and market segment.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 257 pages and 21 tables

Table Of Contents

2017 Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape-US, Europe (France, Germany, Italy, Spain, UK), Japan
Table of Contents

I. Introduction

II. PAP Smear/HPV Worldwide Market and Technology Overview

A. PAP Smear/HPV: Clinical Significance and Laboratory Practices
B. Instrumentation Review And Market Needs
1. Abbott AxSYM
2. Abbott Architect c4000
3. Abbott Architect i2000 Series
4. Abbott Architect ci8200 System
5. Beckman Coulter UniCel Series
6. Beckman Coulter Access
7. Binding Site ESP600
8. bioMerieux Mini Vidas
9. Carolina Chemistries BioLis 24i
10. DiaSorin Liaison
11. Horiba ABX Pentra 400
12. Inverness DS2
13. JandJ Vitros ECi/ECiQ
14. JandJ Vitros 3600
15. JandJ Vitros 5600
16. Olympus AU5400
17. Olympus AU3000i
18. Olympus AU2700
19. Roche Modular Analytics
20. Roche Cobas Integra 400
21. Roche Cobas Integra 400 Plus
22. Roche Elecsys
23. Roche Cobas c311
24. Siemens ADVIA Centaur
25. Siemens Dimension
26. Siemens Dimension RxL Max
27. Siemens Dimension Vista 500
28. Siemens Immulite
29. Siemens Stratus
30. Tosoh AIA-Series
31. Vital Diagnostics ATAC 8000
32. Vital Diagnostics Envoy 500
C. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
D. Personal Testing

III. France: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

VIII. U.K.: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

IX. U.S.A.: Test Volume and Diagnostics Sales Forecast by Market Segment, Supplier Sales and Market Shares

X. Design Criteria for Decentralized Testing Products

XI. Alternative Market Penetration Strategies

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies

1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor

XII. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIII. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics/Theradiag
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix/Clinical Genomics
- Enzo Biochem
- Exact Sciences
- Fujirebio/Innogenetics
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Life Technologies
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics and Therapeutics
- Tosoh
- Veridex
- Vermillion
- Wako Pure Chemicals
- Wallac/PE
- Zila

List of Tables
Major Companies Developing or Marketing Pap Smear/HPV Tests
France PAP Smear Test Volume and Diagnostics Sales by Market Segment
France Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
France PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Germany PAP Smear Test Volume and Diagnostics Sales by Market Segment
Germany Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Germany PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Italy PAP Smear Test Volume and Diagnostics Sales by Market Segment
Italy Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Italy PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Japan PAP Smear Test Volume and Diagnostics Sales by Market Segment
Japan Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Japan PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
Spain PAP Smear Test Volume and Diagnostics Sales by Market Segment
Spain Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Spain PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
U.K. PAP Smear Test Volume and Diagnostics Sales by Market Segment
U.K. Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.K. PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers
U.S.A. Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. PAP Smear/HPV Diagnostic Testing Market Sales and Shares of Leading Suppliers

Company Assessments
- Abbott
- AdnaGen/Alere
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics/Theradiag
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix/Clinical Genomics
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics and Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Pap Smear/Human Papillomavirus (HPV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Pap Smear/Human Papillomavirus (HPV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

  • $ 3500
  • Industry report
  • December 2016
  • by Venture Planning Group

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

2017 Europe Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape-France, Germany, Italy, Spain, UK

2017 Europe Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape-France, Germany, Italy, Spain, UK

  • $ 2850
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $2,850.  DataPack (test volumes, sales forecasts) $1,850.This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including ...

Global Cervical Cancer Diagnostic Testing Market 2016-2020

Global Cervical Cancer Diagnostic Testing Market 2016-2020

  • $ 2500
  • Industry report
  • December 2016
  • by Infiniti Research Limited

About Cervical Cancer Diagnostic Testing The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.